Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

City Therapeutics, founded on Kotaro Nakanishi’s Ohio State research, secures $1 billion collaboration with Biogen

September 12, 2025

City Therapeutics, founded on Kotaro Nakanishi’s Ohio State research, secures $1 billion collaboration with Biogen

Kotaro

City Therapeutics, a company founded by Kotaro, made the news by securing $1 billion collaboration with Biogen.  This exciting news was featured in today’s On Campus. 

Congratulations, Kotaro!